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The mortality rate for patients with Ebola virus disease (EVD) in West Africa is approximately
65% [1]. There are no published figures for high-resource settings, but media sources and indi-
vidual case reports suggest it is much lower and approaches 0% for those who receive this level
of care from the beginning of their illness. In their article “Ebola Viral Disease: Experience and
Decision Making for the First Cases outside of Africa,” David Stephens and colleagues give
insight into the care that can be provided when available resources are not the limiting factor
[2]. They describe the decision to open the Serious Communicable Diseases Unit (SCDU) of
Emory University Hospital (EUH) when two United States patients contracted EVD while
working in West Africa. Using a large specialist team, they provided high-quality care in a safe
working environment and disseminated their knowledge and experience widely. In particular,
they were able to respond to the huge increase in requests from health care facilities in the US
for help in excluding the diagnosis of EVD. Caring for patients using an individualised
approach under ideal circumstances contrasts with, but can also inform, the public health
approach to care under resource-limited conditions in West Africa. The models of care
employed in each environment show some similarities and also have a number of key
differences.
Models of Care
During a generalised outbreak of EVD, a key task is to screen sick patients presenting to health
care facilities. Patients suspected of having EVD must be admitted to an isolation unit, which
itself must isolate patients from one another until EVD testing is complete. Screening algo-
rithms must have a very high negative predictive value to prevent EVD-positive patients being
moved to general wards or discharged home. These units, known as Ebola holding units
(EHUs) in Sierra Leone, were hastily constructed, often from very basic materials when sick
patients began presenting to health care facilities. As a result, many provide far from ideal
working conditions with increased risks of nosocomial transmission.
Once EVD is confirmed, patients can be cohorted together, which means transfer to an
Ebola treatment unit (ETU). Some ETUs are part of the same complex as the EHU, but others
were built at sites away from health care facilities. Their construction was swift, but they were
purpose built and therefore more appropriate for EVD care than many EHUs.
The circumstances were slightly different in the US. There was an increase in suspected cases
of EVD in the whole of the US that coincided with the first patients arriving at EUH, but the
chance of any given patient being positive was much lower. Rather than creating the equivalent
of EHUs, the model was to disseminate knowledge of screening algorithms for use across the
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country, with only a minority of patients requiring isolation. The model of care at EUHwas sim-
ilar to a West African ETU, with patients having EVD confirmed before arrival and being trans-
ferred under the strictest infection prevention and control (IPC) precautions to a pre-existing
purpose-built facility.
Staff Compliment
A leading contrast between West Africa and EUH is the availability of staff resources. Rather
than a large team of specialists caring for one or two patients at a time, a typical EHU such as
at the Connaught hospital in Freetown, Sierra Leone, had a total staff compliment of around 50
and cared for 16–18 patients simultaneously, with multiple admissions, discharges, and deaths
per day. At the height of the epidemic, we estimated total time available to treat a patient was
20 minutes per day [3]. Early in the epidemic, it was estimated that clinical staff had only 1–2
minutes per patient per day to formulate a treatment plan [4]. A key clinical question was how
to spend that time most efficiently and in particular how best to administer fluids to patients.
Fluid Replacement
The predominant clinical features of the EVD outbreak are fever, headache, diarrhoea, and
vomiting [4–7], and patients become severely dehydrated, often developing hypovolaemic
shock. A small number of centres have been able to routinely measure renal function and
found that whereas both hypo- and hypernatraemia occur, hypokalaemia is almost universal
and renal impairment is common [7]. Despite the lack of randomised controlled trials, most
expert guidance has focussed on the importance of replacing fluids and electrolytes, and a key
question is the optimal route of administration. For cooperative patients with mild disease, oral
replacement is appropriate and probably lifesaving. For more severe cases with severe diar-
rhoea, uncontrollable vomiting, or confusion, the ideal route is intravenous, but this presents
several challenges. Early experience at the Connaught hospital was of severe adverse events
such as haemorrhage, probably related to severe thrombocytopenia, particularly when con-
fused patients removed their cannulas. This represented an infection control hazard as well as
an obvious risk to patients. With such limited human resources, it was not possible to inten-
sively nurse or safely sedate patients for this purpose. With so many challenges, few centres
have been able to offer intravenous fluid therapy to the standard of an intensive care facility in
a high-resource setting, and this has undoubtedly contributed to the higher mortality rate.
Because of the challenges of replacing fluids and electrolytes in resource-constrained set-
tings, one possibility is to use antidiarrheal agents to limit gastrointestinal fluid and electrolyte
losses and prevent the problem at its source [8]. A meta-analysis of randomized trials of lopera-
mide in combination with antibiotic therapy for management of infectious diarrhoea in adults
has demonstrated its safety and efficacy [9], and there has been some success in using lopera-
mide during the current outbreak [4].
Biosafety andWaste Disposal
Maintaining high levels of biosecurity in West Africa has been challenging. Supply of personal
protective equipment (PPE) was rarely a problem, but facilities for decontamination, particu-
larly in the hastily constructed EHUs, were often far from ideal. The most vulnerable period is
while doffing PPE, and great care had to be taken to ensure staff safety under these conditions.
Large volumes of dry and wet waste were created at all sites. While some purpose-built EHUs
had state-of-the-art incinerators, many smaller units relied on burning waste in pits, which is
not an ideal practice.
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There is uncertainty regarding optimal IPC precautions for EVD, with each organisation
using slightly different procedures and products. It is important that precautions are both effec-
tive and resource efficient, which is one area in particular in which experience from centres
such as EUH could be used to inform lower-resourced settings.
Point-of-Care Rapid Diagnostic Tests
Point-of-care rapid diagnostic tests (RDTs) have the potential to revolutionise the screening
process for EVD. While sensitive screening algorithms can reduce the volume of patients
admitted to EHUs, definitive diagnosis requires a laboratory-based real-time polymerase chain
reaction (RT-PCR), which is costly and can have a turnaround time of up to 7 days. Isolating
all patients suspected of having EVD is resource intensive; it exposes EVD-negative patients to
risk of nosocomial transmission and delays diagnosis and treatment of their underlying condi-
tion. A clinically useful RDT must be sensitive enough that patients with negative results can
confidently be admitted to general wards or discharged home without risk of onward transmis-
sion. The World Health Organization recently endorsed a RDT with sensitivity of 92% that
does not meet these requirements and is therefore unlikely to be useful clinically [10]. Fortu-
nately, a second test has now been validated on clinical cases and found to have sensitivity of
100% [11]. This test has the potential to dramatically reduce the patient load at EHUs and free
up resources for clinical care.
Strategies for Treating EVD
Research into treatment and prevention strategies has focused on vaccines, antivirals, and con-
valescent blood products. While an efficacious vaccine or a cheap and effective antiviral may be
beneficial in future outbreaks, it is unlikely that convalescent blood products will ever be practi-
cal in low-resource settings even if they prove efficacious. In testing such strategies, resources
have been diverted from trials to optimise the standard of care using easily available treatments
such as antidiarrhoeal agents, antibiotics, and electrolyte replacement. With the end of the out-
break in sight, the opportunity to test these cheap and practical strategies has passed for now.
Conclusion
Caring for patients with EVD using an individualised approach in high-resource settings
reduces mortality towards zero. Mortality is much higher in low-resource settings where a pub-
lic health approach is needed. In such settings, it is vital to use resources in the most efficient
way possible to tip the balance in favour of survival for as many patients as possible.
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